| 产品名称： | Streptomyces aureofaciens Duggar |
|---|---|
| 商品货号： | TS213980 |
| Strain Designations： | E504 |
| Application： | Produces 5-alpha(11-alpha)-dehydrotetracycline Produces 6-demethyltetracycline Produces 7-chloro-6-demethyltetracycline Produces chlortetracycline aureomycin Produces tetracyclines |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1877: ISP Medium 1 ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor： | American Cyanamid Co. |
| U.S. Patent Number： | |
| References： | Miller PA, McCormick JR. Biological transformation of anhydrotetracycline to 5alpha(11alpha)-dehydrotetracyclines. US Patent 2,952,587 dated Sep 13 1960 McCormick JR, et al. Process of producing an antibiotic of the tetracycline series. US Patent 2,970,947 dated Feb 7 1961 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptomyces aureofaciens Duggar |
|---|---|
| 商品货号： | TS213980 |
| Strain Designations： | E504 |
| Application： | Produces 5-alpha(11-alpha)-dehydrotetracycline Produces 6-demethyltetracycline Produces 7-chloro-6-demethyltetracycline Produces chlortetracycline aureomycin Produces tetracyclines |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1877: ISP Medium 1 ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor： | American Cyanamid Co. |
| U.S. Patent Number： | |
| References： | Miller PA, McCormick JR. Biological transformation of anhydrotetracycline to 5alpha(11alpha)-dehydrotetracyclines. US Patent 2,952,587 dated Sep 13 1960 McCormick JR, et al. Process of producing an antibiotic of the tetracycline series. US Patent 2,970,947 dated Feb 7 1961 |
